https://www.selleckchem.com/products/btx-a51.html
At 2months after implantation, bowel health-related quality of life was worse with I; however, this difference was lost at subsequent time points. The 9-year BRFS was 87.2% and 84.0% for the I and Cs group, respectively (p= 0.897). There was no statistically significant difference in BRFS based on initial T stage, PSA, or Gleason score. Short- and long-term urinary, ****ual, and bowel quality of life, as well as long-term biochemical control were comparable between I and Cs. This report therefore supports the continued use of Cs as an ef
כמו
תגובה
לַחֲלוֹק
